Oracle posted its fiscal second-quarter adjusted earnings of $1.21 a share, beating analysts’ expectations of $1.17 a share (according to FactSet). The cloud giant’s revenue came in at $12.28 billion, vs. analysts’ forecast of $11.96 billion (according to FactSet.).
For the fiscal third quarter, CEO Safra Catz said revenue growth should be 17% to 19% from last year, (implying a revenue range of around $12.3 billion to $12.5 billion). Catz indicated that the company is expecting adjusted earnings of $1.17 a share to $1.21 a share, vs. analysts’ expectations of $1.23 a share (according to FactSet).
Oracle growth prospects look healthy, with the company completing its acquisition of healthcare-focused company Cerner in a $28 billion deal. The company recently bagged a part of a recent Defense Department contract after suing to halt an earlier version of that award.
ORCL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 35 cases where ORCL's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ORCL advanced for three days, in of 351 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 335 cases where ORCL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for ORCL moved out of overbought territory on November 25, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 52 similar instances where the indicator moved out of overbought territory. In of the 52 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on November 27, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on ORCL as a result. In of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for ORCL turned negative on November 26, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ORCL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. ORCL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (61.350) is normal, around the industry mean (30.859). P/E Ratio (33.108) is within average values for comparable stocks, (159.968). Projected Growth (PEG Ratio) (1.057) is also within normal values, averaging (2.755). Dividend Yield (0.013) settles around the average of (0.084) among similar stocks. P/S Ratio (6.720) is also within normal values, averaging (57.731).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of a diversified line of business software products
Industry PackagedSoftware